Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Centessa Pharmaceuticals plc Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 HUSSAIN IQBAL J (General Counsel) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 7,520 shares @ $6.47, valued at $48.7k
10/03/2023 4 GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 4,700 shares @ $6.47, valued at $30.4k
10/03/2023 4 Weinhoff Gregory M (CFO) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 11,742 shares @ $6.47, valued at $76k
10/03/2023 4 SAHA SAURABH (CEO) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 36,263 shares @ $6.47, valued at $234.6k
10/03/2023 4 CHAO DAVID M (Chief Administrative Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 10,419 shares @ $6.47, valued at $67.4k
10/03/2023 4 Bush Tia L (Chief Quality Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 6,419 shares @ $6.47, valued at $41.5k
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 Weinhoff Gregory M (CFO) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 11,742 shares @ $5.9001, valued at $69.3k
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2023 4 YVER ANTOINE (EVP & Chairman of Development) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Sold 6,500 shares @ $4.4537, valued at $28.9k
05/26/2023 4 Bush Tia L (Chief Quality Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Sold 5,000 shares @ $4.485, valued at $22.4k
Sold 3,000 shares @ $4.4801, valued at $13.4k
05/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2023 4 CHAO DAVID M (Chief Administrative Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 6,969 shares @ $3.9, valued at $27.2k
04/04/2023 4 Weinhoff Gregory M (CFO) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 8,292 shares @ $3.9, valued at $32.3k
04/04/2023 4 Templeman Thomas (Chief Technology Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 4,103 shares @ $3.9, valued at $16k
04/04/2023 4 SAHA SAURABH (CEO) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 22,013 shares @ $3.9, valued at $85.9k
04/04/2023 4 HUSSAIN IQBAL J (General Counsel) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 7,080 shares @ $3.9, valued at $27.6k
04/04/2023 4 YVER ANTOINE (EVP & Chairman of Development) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 3,615 shares @ $3.9, valued at $14.1k
Sold 6,700 shares @ $3.691, valued at $24.7k
04/04/2023 4 GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 4,825 shares @ $3.9, valued at $18.8k
04/04/2023 4 Bush Tia L (Chief Quality Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 4,319 shares @ $3.9, valued at $16.8k
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/13/2023 4 Templeman Thomas (Chief Technology Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 5,382 shares @ $4.25, valued at $22.9k
01/13/2023 4 GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 7,154 shares @ $4.25, valued at $30.4k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy